Class information for:
Level 2: RADIOIMMUNOTHERAPY//NUCLEAR MEDICINE AND BIOLOGY//ANTIBODY DRUG CONJUGATE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
808 12023 35.1 75%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
416 3       NEUROENDOCRINE TUMORS//CARCINOID//SMALL CELL CARCINOMA 28897
808 2             RADIOIMMUNOTHERAPY//NUCLEAR MEDICINE AND BIOLOGY//ANTIBODY DRUG CONJUGATE 12023
411 1                   RADIOIMMUNOTHERAPY//ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//IMMUNOSCINTIGRAPHY 3512
2534 1                   PEPTIDE RECEPTOR RADIONUCLIDE THERAPY//RADIOL CHEM//PRRT 2215
11281 1                   ANTIBODY DRUG CONJUGATE//GEMTUZUMAB OZOGAMICIN//MYLOTARG 994
11850 1                   AT 211//ASTATINE//TARGETED ALPHA THERAPY 949
12872 1                   EPCAM//TROP2//EP CAM 875
13646 1                   AFFIBODY MOLECULE//AFFIBODY//BIOMED RADIAT SCI 822
15894 1                   AUGER ELECTRONS//AUGER ELECTRON EMITTERS//CELLULAR DOSIMETRY 685
16557 1                   FLUOROESTRADIOL//F 18 FES PET//F 18FES 647
18119 1                   PRETARGETING//PRETARGETED RADIOIMMUNOTHERAPY//MOL MED IMMUNOL 565
20544 1                   MELANOMA IMAGING//IMAGERIE MOL THER IE VECTORISEE//ALPHA MELANOCYTE STIMULATING HORMONE HYBRID PEPTIDE 456
28336 1                   RADIOIODINATION//PROSTHETIC RADIOIODINATION//ELED COMPOUND 209
35662 1                   A33 ANTIGEN//ADHESION REGULATING MOLECULE 1//ADRM1 94

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 RADIOIMMUNOTHERAPY authKW 792433 5% 50% 626
2 NUCLEAR MEDICINE AND BIOLOGY journal 284994 5% 18% 643
3 ANTIBODY DRUG CONJUGATE authKW 250017 2% 54% 182
4 JOURNAL OF NUCLEAR MEDICINE journal 221481 8% 9% 942
5 AFFIBODY MOLECULE authKW 193480 1% 89% 86
6 PRETARGETING authKW 189242 1% 72% 104
7 NUCL MED address 175926 14% 4% 1708
8 ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS journal 160917 1% 62% 102
9 RADIOL CHEM address 138552 1% 73% 75
10 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY authKW 137218 1% 72% 75

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Radiology, Nuclear Medicine & Medical Imaging 97828 35% 1% 4231
2 Oncology 36272 29% 0% 3537
3 Nuclear Science & Technology 4331 6% 0% 755
4 Biochemical Research Methods 4200 7% 0% 855
5 Chemistry, Medicinal 1786 4% 0% 525
6 Medicine, Research & Experimental 1666 6% 0% 668
7 Chemistry, Inorganic & Nuclear 1055 4% 0% 530
8 Chemistry, Organic 835 5% 0% 658
9 Pharmacology & Pharmacy 678 7% 0% 856
10 Immunology 589 5% 0% 637

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 NUCL MED 175926 14% 4% 1708
2 RADIOL CHEM 138552 1% 73% 75
3 BIOMED RADIAT SCI 119318 1% 52% 91
4 UNIT BIOMED RADIAT SCI 98089 0% 67% 58
5 RADIOIMMUNE INORGAN CHEM SECT 86434 1% 45% 75
6 CELL BIOL EXPT CANC 84922 1% 44% 77
7 GARDEN STATE CANC 62812 0% 49% 51
8 PRECLIN PET PLATFORM 59876 0% 54% 44
9 MOL MED IMMUNOL 46237 0% 40% 46
10 RADIAT ONCOL BRANCH 43158 1% 16% 108

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NUCLEAR MEDICINE AND BIOLOGY 284994 5% 18% 643
2 JOURNAL OF NUCLEAR MEDICINE 221481 8% 9% 942
3 ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS 160917 1% 62% 102
4 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 126537 2% 19% 270
5 BIOCONJUGATE CHEMISTRY 74258 3% 8% 383
6 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 61399 2% 9% 279
7 EUROPEAN JOURNAL OF NUCLEAR MEDICINE 31712 2% 6% 202
8 EJNMMI RESEARCH 23623 1% 15% 64
9 NUCLEAR MEDICINE COMMUNICATIONS 21329 2% 5% 188
10 CANCER RESEARCH 19655 5% 1% 560

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 RADIOIMMUNOTHERAPY 792433 5% 50% 626 Search RADIOIMMUNOTHERAPY Search RADIOIMMUNOTHERAPY
2 ANTIBODY DRUG CONJUGATE 250017 2% 54% 182 Search ANTIBODY+DRUG+CONJUGATE Search ANTIBODY+DRUG+CONJUGATE
3 AFFIBODY MOLECULE 193480 1% 89% 86 Search AFFIBODY+MOLECULE Search AFFIBODY+MOLECULE
4 PRETARGETING 189242 1% 72% 104 Search PRETARGETING Search PRETARGETING
5 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY 137218 1% 72% 75 Search PEPTIDE+RECEPTOR+RADIONUCLIDE+THERAPY Search PEPTIDE+RECEPTOR+RADIONUCLIDE+THERAPY
6 EPCAM 130559 1% 42% 122 Search EPCAM Search EPCAM
7 PRRT 123717 1% 76% 64 Search PRRT Search PRRT
8 GEMTUZUMAB OZOGAMICIN 123275 1% 63% 77 Search GEMTUZUMAB+OZOGAMICIN Search GEMTUZUMAB+OZOGAMICIN
9 AT 211 117862 0% 91% 51 Search AT+211 Search AT+211
10 SOMATOSTATIN RECEPTOR SCINTIGRAPHY 116841 1% 48% 96 Search SOMATOSTATIN+RECEPTOR+SCINTIGRAPHY Search SOMATOSTATIN+RECEPTOR+SCINTIGRAPHY

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 EBERLE, AN , MILD, G , FROIDEVAUX, S , (2004) RECEPTOR-MEDIATED TUMOR TARGETING WITH RADIOPEPTIDES. PART 1. GENERAL CONCEPTS AND METHODS: APPLICATIONS TO SOMATOSTATIN RECEPTOR-EXPRESSING TUMORS.JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION. VOL. 24. ISSUE 4. P. 319-455 317 58% 10
2 SEIDL, C , (2014) RADIOIMMUNOTHERAPY WITH A- PARTICLE- EMITTING RADIONUCLIDES.IMMUNOTHERAPY. VOL. 6. ISSUE 4. P. 431 -458 128 85% 9
3 WALTER, RB , PRESS, OW , PAGEL, JM , (2010) PRETARGETED RADIOIMMUNOTHERAPY FOR HEMATOLOGIC AND OTHER MALIGNANCIES.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 25. ISSUE 2. P. 125-142 124 85% 14
4 KIM, YS , BRECHBIEL, MW , (2012) AN OVERVIEW OF TARGETED ALPHA THERAPY.TUMOR BIOLOGY. VOL. 33. ISSUE 3. P. 573-590 94 95% 38
5 FANI, M , MAECKE, HR , OKARVI, SM , (2012) RADIOLABELED PEPTIDES: VALUABLE TOOLS FOR THE DETECTION AND TREATMENT OF CANCER.THERANOSTICS. VOL. 2. ISSUE 5. P. 481-501 102 76% 85
6 SCHOTTELIUS, M , WESTER, HJ , (2009) MOLECULAR IMAGING TARGETING PEPTIDE RECEPTORS.METHODS. VOL. 48. ISSUE 2. P. 161 -177 133 65% 111
7 TOLMACHEV, V , ORLOVA, A , (2010) INFLUENCE OF LABELLING METHODS ON BIODISTRIBUTION AND IMAGING PROPERTIES OF RADIOLABELLED PEPTIDES FOR VISUALISATION OF MOLECULAR THERAPEUTIC TARGETS.CURRENT MEDICINAL CHEMISTRY. VOL. 17. ISSUE 24. P. 2636-2655 141 68% 27
8 POTAMIANOS, S , VARVARIGOU, AD , ARCHIMANDRITIS, SC , (2000) RADIOIMMUNOSCINTIGRAPHY AND RADIOIMMUNOTHERAPY IN CANCER: PRINCIPLES AND APPLICATION.ANTICANCER RESEARCH. VOL. 20. ISSUE 2A. P. 925-948 143 89% 22
9 TOMBLYN, MB , KATIN, MJ , WALLNER, PE , (2013) THE NEW GOLDEN ERA FOR RADLOIMMUNOTHERAPY: NOT JUST FOR LYMPHOMAS ANYMORE.CANCER CONTROL. VOL. 20. ISSUE 1. P. 60-71 109 76% 14
10 VELIKYAN, I , (2014) PROSPECTIVE OF GA-68-RADIOPHARMACEUTICAL DEVELOPMENT.THERANOSTICS. VOL. 4. ISSUE 1. P. 47 -80 131 47% 48

Classes with closest relation at Level 2


Rank Class id link
1 2747 EXCITATION FUNCTION//INTEGRAL YIELD//THICK TARGET YIELD
2 1834 PHAGE DISPLAY//ANTIBODY ENGINEERING//BISPECIFIC ANTIBODY
3 1290 SCINTIMAMMOGRAPHY//TECHNETIUM 99M//CLINICAL NUCLEAR MEDICINE
4 1876 RIBOSOME INACTIVATING PROTEIN//RICIN//TRICHOSANTHIN
5 1647 ABDOMINAL COMPARTMENT SYNDROME//SOMATOSTATIN RECEPTOR//SOMATOSTATIN
6 957 PET CT//NUCL MED//PET
7 643 NEUROENDOCRINE TUMORS//CARCINOID//SMALL CELL CARCINOMA
8 1798 DUAL ENERGY CT//RADIATION DOSE//ITERATIVE RECONSTRUCTION
9 3451 HUMAN HUMAN HYBRIDOMA//IMMUNOGLOBULIN PRODUCTION STIMULATING FACTOR//HYBRIDOMA
10 1581 CYFRA 21 1//CEA//CARCINOEMBRYONIC ANTIGEN

Go to start page